Navigation Links
SNM and ASTRO team up to advance molecular imaging and cancer research
Date:8/22/2008

RESTON, Va.SNM and the American Society for Therapeutic Radiation and Oncology (ASTRO) will cosponsor a symposium this fall examining the impact of translational advances on radiation oncology and cancer imaging. The two-day meeting, which takes place October 17-18, will bring together some of the world's leading experts and young investigators in the emerging field of molecular imaging.

"Collaborative forums, such as this meeting exploring intersections of molecular imaging and oncology, are critical to advancing our understanding of the underlying causes of disease," said SNM President Robert W. Atcher, Ph.D., M.B.A., emerging medical technology team leader at Los Alamos National Laboratory in New Mexico and UNM/LANL Professor of Pharmacy at the University of New Mexico. "Continuing education and opportunities for colleagues to share research are essential to advancing the practice of molecular imagingand to helping patients and their care givers gain the vital information they need in order to effectively treat disease as early as possible."

SNM's support of ASTRO's translational symposium is part of the society's broader initiative to partner with other organizations to bring the latest in molecular imaging research to patients. In SNM's initial inter-societal collaboration, SNM and the American Society of Clinical Oncology (ASCO) developed a joint seminar on optimizing clinical trials, which was presented at the ASCO Annual Meeting, held in early June in Chicago, Ill., as well as at the SNM Annual Meeting in New Orleans, La., a few weeks later.

"As organizations whose missions focus on advancing health care, we must work together to meet the continual challenges that patients face in order to bring breakthrough technologies and treatments to the patient," said Chaitanya Divgi, M.D., chief of nuclear medicine and professor of radiology at the University of Pennsylvania, who co-organized this symposium. "Molecular imaging is an integral step toward achieving the goal of personalized medicine, which promises to deliver specifically targeted treatments to individuals."

The ASTRO symposium, Translational Advances in Radiation Oncology and Cancer Imaging, will be held at the Westin Arlington Gateway in Arlington, Va. and will bring medical professionals and scientists together to explore and share research on the uses of molecular imaging in the detection, diagnosis and treatment of cancer. Additional supporters of this meeting include the Radiological Society of North America and Radiation Therapy Oncology Group.

Molecular imaging is an essential component for the early detection and diagnosis of many types of cancer, including ovarian, cervical, lung and prostate cancer. Using state-of-the-art equipment and precisely targeted tracers, molecular imaging enables physicians to see how disease functions within the body.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
2. Genomma Lab Internacional Acquires UNIGASTROZOL
3. Sports Luminaries Andre Agassi, Jerry Rice, Scottie Pippen, Helio Castrovenes, Richard Goose Gossage Among Those Named 2008 Great Sports Legends
4. MDCT, virtual gastroscopy and MPR images differentiate malignant and benign gastric ulcers
5. July 2008 Mayo Clinic Womens HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease
6. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
7. Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider.
8. ASTRO, The Wellness Community - Greater Boston Join to Promote Cancer Survivorship
9. 10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain
10. 7 outstanding young gastroenterologists receive AGA Foundation 2008 Research Scholars Award
11. ASTRO announces 2008 gold medalists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... PhD, announced at his Inauguration that WesternU will move forward in bold new ... compass. , WesternU combined Wilson’s Inauguration ceremony with Convocation, the traditional opening of ...
(Date:8/15/2017)... Philadelphia, PA (PRWEB) , ... August 15, 2017 , ... ... they have embarked on a new three-year partnership to expand the City’s commitment to ... AACR supports activities that encourage the public to lead a healthy lifestyle as research ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading dental marketing ... Fast 50 list of Fastest Growing Companies in Tampa Bay. The Tampa Bay Business ... shown three consecutive years of growth. For this year’s award, Progressive Dental ranked number ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Richard Amato is raising ... as a periodontist in Monroe, CT since 1989, Dr. Amato understands that ... is educating his community on how to choose the right clinician for their periodontal ...
(Date:8/15/2017)... Louis Park, Minnesota (PRWEB) , ... August 15, 2017 , ... ... the Hearing Loss Association of America’s HLAA Twin Cities Living Well with Hearing Loss ... Monterey Drive, St. Louis Park, Minnesota. Look for Harris Communications at tables 8 and ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/2/2017)... 2, 2017  Life Flight Network and PeaceHealth Oregon Network ... patient care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, ... and Life Flight Network work collaboratively to move patients who ... when a time sensitive emergency exists. ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology: